Member Info for krafty1305

Crumbs, totally agree. Our submission would have been in on May 31st and 3 weeks later phase 1 detail was announced . Next is results from phase 1 which should not take too long. All is in place and when collaborations are required with big pharma, government and hopefully Cepi to create worldwide manufacturing and distribution that will happen when it is right to do so. The dice have been rolled

to 22.50/23.0 nice to see the momentum continuing. 23p paid

For a proper article I would imagine additional research would be required including interviews. So hopefully something by the weekend. That would be much better than a rehashed RNS with errors due to misunderstanding.

thats nicely presented

Boris doing a press conference on Monday. He will have to mention something about the new science committee he is heading.

There is a mix of possibilities with Cepi and UK government involvement.

Bill, the link you provided was from April last year. Was that an error?

agreed. saying I think we have solved Covid is a very big thing to digest. But Cepi understand it all and that will be very useful in our progress

A government press conference announcing trials like Oxford got at this stage wouldn't
do any harm!

totally agree. What is going through my brain is that we are doing the phase 1 independently which just put the pice up if all goes as planned

Targeting only the 'S' protein means the virus and its mutations will always be ahead of the vaccine. Targeting the 'N' protein means the vaccine will be ahead of the virus. Have contacted Rigby on Twitter from the Telegraph who broke the Cepi story so hopefully she will follow up. We have contacted each other on Twitter before.

Was also wondering the timing of Johnson's Science announcement was rather good. What better than UK sorting out Covid for the world to establish UK as leading science nation. Then of course leading the world in cancer treatment would be a pretty big coup as well.

Chester, I agree. Its only because of what Cepi are saying I am so optimistic and I hope this is the route as their track record in last year is phenomenal. Not sure how many realise on here their input on the AZ/Oxford vaccine

HI C7. the closing dates for submissions was May 31st, giving only 2 months to come up with a viable universal vaccine which did put us at an advantage. so all the different scenarios come in to play. We would be far the smallest company Cepi would have invested in so I am assuming/hoping the delay is do with partnerships or even the potential buy out. And if there was a buy out, that would explain the delays for the other trials. On the other hand, as Topol would say, the recruitment for trial staff implies Scancell are gearing up for doing the trials themselves. Truth is of course we have no idea and await that elusive red dot at 7am every morning!

"Given these promising areas of work, CEPI is also exploring the need to develop a broadly protective coronavirus vaccine, with further details on our work to be provided in the coming weeks."

This is the highlighted summary quote from the end of the article. A few weeks later, there was the call for submissions for the project and now just waiting for the 'winners' to be announced from the resulting cash call to fund the trials.

They only mention 2 projects in this constant retweet, one of which is ours. So yes it would be very strange if the partnership was not to happen.

logic says that as Curevac is a Cepi backed project, they may well redouble efforts to find a universal vaccine as per the March 1st article

https://cepi.net/news_cepi/going-universal-the-search-for-an-all-in-one-coronavirus-vaccine/

Appointing a healthcare mergers and acquisition specialist a a joint broker is price sensitive which is why there was an RNS yesterday. And the BOD decided it was more so than the points discussed below. Which is why I was excited and intrigued on yesterday's announcement.

Max. My headline would have been 'Scancell appoint healthcare M&A specialist as broker' which I assume is what you are getting at. It seems that is not Scancell's way. But the fact remains they have actually done that which is the more important thing. A more punchy headline would for sure allowed for more day trading and may be allowed for some to take some profits. All I will say it was significant enough to warrant an RNS and should be seen in that context.

obviously meaning if Cepi is not on board I would be deeply upset

I think my speculation that Stifel has been appointed due to their expertise in 'M&A' in the healthcare sector has been missed due to the Moditope change in the RNS. Anyone else have an opinion on this? Of course this brings about the question of £, especially if Cepi is on board which I would be deeply upset with due to the obvious need for a Universal Vaccine but also the need for a major pharma to produce the billions required to vaccinate the world in terms of manufacture and distribution

From Stifel Website
"Stifel’s Global Healthcare Investment Banking Group is comprised of 47 professionals covering all segments of the healthcare industry. The team, located in New York, San Francisco and London, has substantial experience in assisting companies with all types of financing and M&A assignments. The Global Healthcare Group is dedicated to building long-term relationships with its clients through senior level attention. Since the formation of the Global Healthcare Group in Q4 2010, the team have helped raise over $79.1 billion for over 225 healthcare companies in over 440 transactions. Over the same period, members of the Global Healthcare Group have advised on over 105 announced M&A transactions, including over 30 cross-border assignments."

Lots of talk about "M&A" in health sector, specifically on cross border deals. One good reason to appoint them. Lots of opportunity for us on Team Ramp to extrapolate on this one.